Wolverine Trading
LAB icon

Wolverine Trading’s Standard BioTools LAB Stock Holding History

Wolverine Trading’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,808
Closed -$26.5K – 5599
2024
Q3 		$26.5K Buy
+13,808
New +$27K ﹤0.01% 4607
2022
Q1 		– Sell
-10,656
Closed -$40K – 5966
2021
Q4 		$40K Sell
10,656
-1,474
-12% -$6.9K ﹤0.01% 5389
2021
Q3 		$77K Buy
+12,130
New +$79.8K ﹤0.01% 5894
2021
Q2 		– Sell
-29,731
Closed -$128K – 6385
2021
Q1 		$128K Buy
29,731
+2,832
+11% +$15.6K ﹤0.01% 5320
2020
Q4 		$163K Sell
26,899
-22,905
-46% -$150K ﹤0.01% 4327
2020
Q3 		$382K Buy
49,804
+37,669
+310% +$260K ﹤0.01% 3107
2020
Q2 		$50K Buy
+12,135
New +$42.3K ﹤0.01% 4312
2019
Q4 		– Sell
-10,351
Closed -$49K – 4939
2019
Q3 		$49K Buy
+10,351
New +$81.5K ﹤0.01% 4052
2017
Q2 		– Sell
-14,831
Closed -$84K – 4659
2017
Q1 		$84K Buy
+14,831
New +$94K ﹤0.01% 3876

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Wolverine Trading's LAB Position: Q4 2024 in Review

Wolverine Trading sold out of Standard BioTools (LAB) in Q4 2024, closing a stake of 13,808 shares — an estimated $26.5K sold.

Wolverine Trading first reported a position in LAB in Q1 2017 and held it in 9 quarters. The position peaked at $382K in Q3 2020. 142 funds tracked by Wall St. Rank hold LAB as of Q4 2024.

  • Wolverine Trading reported no remaining Standard BioTools position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 13,808 Standard BioTools shares in Q4 2024, an estimated $26.5K.
  • Wolverine Trading first reported a position in Standard BioTools in Q1 2017 and held it in 9 quarters.
  • Wolverine Trading's Standard BioTools position peaked at $382K in Q3 2020.
  • 142 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.